Company intelligence / Profile preview

Bain Capital

Boston, Massachusetts, United States

Ownership: Private
Employees: ~1600
Development stage: Other

Overview

Bain Capital’s healthcare/life sciences divisions invest and create companies in biotech, pharma, medical devices, healthcare IT, diagnostics, and life science tools. Since its inception, Bain Capital Life Sciences has invested in over 70 companies with >100 clinical trials and 16 regulatory approvals; it backs companies by providing scale-up investment for clinical development, geographic expansion, and strategic restructuring.

Therapeutic areas: ImmunologyMetabolic DisordersInfectious DiseasesDermatologyCardiovascularOncologyNeurology
Modalities: Small moleculeMonoclonal antibodyAntibody-drug conjugateFusion proteinGene therapyCell therapyBiologicPeptides
Industry: Investors

Partnerships

PfizerBristol Myers SquibbCerevel Therapeutics (co-created)immunology startup with Bristol Myers Squibb (co-created)

Beyond the preview

Go deeper on Bain Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bain Capital.

Explore the full profile